Skip to main content
. 2018 Mar-Apr;20(93):47–52. doi: 10.4103/nah.NAH_31_17

Table 3.

Comparison of mean amount of apoptotic OHCs and IHCs identified using Caspase-3 method on the 3rd, 7th and 14th days

Control1 Min–Max (median) Mean ± SD Papaverine2 Min–Max (median) Mean ± SD Piracetam3 Min–Max (median) Mean ± SD P a P b
OHC
 Day 3 165–189 (175.5) 141–159 (148.5) 90–132 (109.5) 0.001** 1,2 0.007**
177.00 ± 7.32 148.90 ± 4.93 109.90 ± 13.75 1,3 0.001**
2,3 0.001**
 Day 7 129–144 (135) 114–138 (122) 101–123 (115.5) 0.001** 1,2 0.001**
136.00 ± 4.67 123.00 ± 6.67 114.90 ± 6.56 1,3 0.001**
2,3 0.015*
 Day 14 93–120 (106.5) 72–91 (82.5) 104–120 (111) 0.001** 1,2 0.001**
106.80 ± 7.57 81.90 ± 6.54 104.50 ± 4.60 1,30.403
2,3 0.001**
IHC
 Day 3 34–39 (36.5) 25–31 (28) 17–26 (20.5) 0.001** 1,2 0.001**
36.50 ± 1.58 28.10 ± 1.91 20.70 ± 3.27 1,3 0.001**
2,3 0.001**
 Day 7 23–28 (25.5) 20–27 (23.5) 19–24 (21.5) 0.001** 1,2 0.036*
25.60 ± 1.71 23.50 ± 2.17 21.50 ± 1.58 1–3 0.001**
2,3 0.039*
 Day 14 18–24 (21) 15–24 (17.5) 16–30 (22.5) 0.005** 1,2 0.004**
21.00 ± 2.05 17.80 ± 1.93 20.70 ± 1.94 1,30.818
2,3 0.005**
a

Kruskal–Wallis test. bMann–Whitney U test. *P < 0.05. **P < 0.01.